There are no items in your cart
You probably think premature babies are Mater's tiniest, most vulnerable patients. But as mum-to-be Kate discovered, some babies need surgery before they are even born.
To save their lives it’s vital that, together, we invest in the latest medical advances in maternal fetal medicine.
When Kate and Michael found out they were expecting identical twins, they were simply twice as joyful, twice as excited. But then they discovered that their babies had a potentially fatal condition.
Kate’s little girls had twin-to-twin transfusion syndrome, which means one of the babies was supplying blood to the other. Their volumes of blood were imbalanced and both babies were in danger.
Not long ago, only one in ten babies diagnosed with twin-to-twin transfusion syndrome survived.
It was a terrifying time for Kate and Michael.
“We didn't know if we were going to have one baby, two babies or any baby,” remembers Kate.
Fifteen years ago that surgery simply wasn’t available in Australia.
But generous people like you have helped raise the money needed to invest in the medical equipment and training required to bring this surgery to Australia—and Mater Mothers’ became the first hospital in the country to offer this kind of treatment.
Thankfully, Kate’s ground-breaking surgery went as planned and, at 35 weeks, Kate went into labour.
Twins Charlotte and Chelsea were born healthy—Kate held one beautiful baby girl in her arms, while Michael gently held the other.
Your help can keep Mater at the forefront of maternal fetal medicine—and help save tiny lives.
Our doctors and researchers count on the support of generous people like you to enable Mater to continue to invest in the latest life-saving medical technology and surgical techniques in maternal fetal medicine.